Alzheimer's Research

Nexalin Technology Advances FDA Strategy for Alzheimer's Treatment Following U.S. and China Leadership Meetings

Nexalin Technology completes strategic meetings in U.S. and China to advance FDA clinical strategy for Alzheimer's treatment using DIFS brain stimulation technology.